Additionally, they observed a well correlation between expression of PD-L1 on dendritic cells (DCs)/macrophages and the efficacy of treatments with either anti–PD-1 alone or in combination with anti-CTLA-4 in ovarian cancer and melanoma patients. This evidence concerns the gene CD274 and melanoma.